Completed Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma NCT03082534 Conditions Carcinoma, Carcinoma, Squamous Cell, Cutaneous Squamous Cell Carcinoma, +37 more Locations UCSD Moores Cancer Center — La Jolla, California, United States University of California Los Angeles Cancer Center — Los Angeles, California, United States University of Michigan Cancer Center — Ann Arbor, Michigan, United States Washington School of Medicine Cancer Center — St Louis, Missouri, United States View Trial Details
